Signaling through delta opioid receptors on murine splenic T cells and stably transf ected jurkat cells

Burt Sharp, David J. Mckean, Kathy Mcallen, Nahid A. Shahabi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

β-Endorphin (β-EP) and delta opoid receptor (DOR) agonists affect immune functions such as lymphocyte chemotaxis, proliferation, and cytokine production. Recent studies indicate that both neuronal DOR and novel G-protein-coupled receptors with high affinity for β-EP and DOR agonists are expressed by mononuclear cells. In addition, proenkephalin A mRNA and enkephalin-related peptides are expressed by lymphocytes. These investigations were conducted to identify signal transduction pathways that mediate the effects of β-EP and DOR agonists on T cells. Calcium mobilization was studied because it is central to T-cell activation initiated by antigen presentation to the T-cell receptor (TCR). Using the calcium-sensitive dye Fluo-3 and flow cytofluorometry to determine the concentration of free intracellular calcium, physiological concentrations of β-EP were shown to enhance concanvalin. A (con A)-stimulated calcium mobilization by murine splenic T cells (p < 0.01). The DOR antagonist, naltrindole, inhibited this, whereas CTAP, a selective mu OR antagonist, was ineffective. In addition, N-Ac-β-EP and the μ OR agonist DAMGO, failed to mimic the effects of β-EP. Although it was less potent than β-EP, DADLE, a DOR agonist, also enhanced Con-A-induced calcium mobilization (p < 0.01). A DORtransfected human T-cell line (DOR-Jul.l) was developed to study signal transduction. Both DADLE and the selective DOR agonist, deltorphin, rapidly increased intracellular free calcium concentrations; ED50s were 10-9 M. Pertussis toxin prevented the response, and EGTA significantly reduced it. In addition, DADLE inhibited forskolin-stimulated cAMP production (ED50: 10-11 M). These findings with normal splenic T cells and DOR-transfected T-cell line indicate that β-EP and DOR agonists affect calcium mobilization. This is likely to modulate downstream pathways that regulate T-cell activation and function.

Original languageEnglish (US)
Pages (from-to)420-421
Number of pages2
JournalAnnals of the New York Academy of Sciences
Volume840
StatePublished - May 1 1998

Fingerprint

delta Opioid Receptor
Jurkat Cells
T-cells
T-Lymphocytes
Leucine-2-Alanine Enkephalin
Calcium
Signal transduction
naltrindole
Lymphocytes
Signal Transduction
CD27 Antigens
Cells
Ala(2)-MePhe(4)-Gly(5)-enkephalin
Endorphins
Cell Line
Enkephalins
Egtazic Acid
Pertussis Toxin
Antigen Presentation
Colforsin

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Signaling through delta opioid receptors on murine splenic T cells and stably transf ected jurkat cells. / Sharp, Burt; Mckean, David J.; Mcallen, Kathy; Shahabi, Nahid A.

In: Annals of the New York Academy of Sciences, Vol. 840, 01.05.1998, p. 420-421.

Research output: Contribution to journalArticle

@article{6a3f3c31d07740e285ea21bb418aeda3,
title = "Signaling through delta opioid receptors on murine splenic T cells and stably transf ected jurkat cells",
abstract = "β-Endorphin (β-EP) and delta opoid receptor (DOR) agonists affect immune functions such as lymphocyte chemotaxis, proliferation, and cytokine production. Recent studies indicate that both neuronal DOR and novel G-protein-coupled receptors with high affinity for β-EP and DOR agonists are expressed by mononuclear cells. In addition, proenkephalin A mRNA and enkephalin-related peptides are expressed by lymphocytes. These investigations were conducted to identify signal transduction pathways that mediate the effects of β-EP and DOR agonists on T cells. Calcium mobilization was studied because it is central to T-cell activation initiated by antigen presentation to the T-cell receptor (TCR). Using the calcium-sensitive dye Fluo-3 and flow cytofluorometry to determine the concentration of free intracellular calcium, physiological concentrations of β-EP were shown to enhance concanvalin. A (con A)-stimulated calcium mobilization by murine splenic T cells (p < 0.01). The DOR antagonist, naltrindole, inhibited this, whereas CTAP, a selective mu OR antagonist, was ineffective. In addition, N-Ac-β-EP and the μ OR agonist DAMGO, failed to mimic the effects of β-EP. Although it was less potent than β-EP, DADLE, a DOR agonist, also enhanced Con-A-induced calcium mobilization (p < 0.01). A DORtransfected human T-cell line (DOR-Jul.l) was developed to study signal transduction. Both DADLE and the selective DOR agonist, deltorphin, rapidly increased intracellular free calcium concentrations; ED50s were 10-9 M. Pertussis toxin prevented the response, and EGTA significantly reduced it. In addition, DADLE inhibited forskolin-stimulated cAMP production (ED50: 10-11 M). These findings with normal splenic T cells and DOR-transfected T-cell line indicate that β-EP and DOR agonists affect calcium mobilization. This is likely to modulate downstream pathways that regulate T-cell activation and function.",
author = "Burt Sharp and Mckean, {David J.} and Kathy Mcallen and Shahabi, {Nahid A.}",
year = "1998",
month = "5",
day = "1",
language = "English (US)",
volume = "840",
pages = "420--421",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Signaling through delta opioid receptors on murine splenic T cells and stably transf ected jurkat cells

AU - Sharp, Burt

AU - Mckean, David J.

AU - Mcallen, Kathy

AU - Shahabi, Nahid A.

PY - 1998/5/1

Y1 - 1998/5/1

N2 - β-Endorphin (β-EP) and delta opoid receptor (DOR) agonists affect immune functions such as lymphocyte chemotaxis, proliferation, and cytokine production. Recent studies indicate that both neuronal DOR and novel G-protein-coupled receptors with high affinity for β-EP and DOR agonists are expressed by mononuclear cells. In addition, proenkephalin A mRNA and enkephalin-related peptides are expressed by lymphocytes. These investigations were conducted to identify signal transduction pathways that mediate the effects of β-EP and DOR agonists on T cells. Calcium mobilization was studied because it is central to T-cell activation initiated by antigen presentation to the T-cell receptor (TCR). Using the calcium-sensitive dye Fluo-3 and flow cytofluorometry to determine the concentration of free intracellular calcium, physiological concentrations of β-EP were shown to enhance concanvalin. A (con A)-stimulated calcium mobilization by murine splenic T cells (p < 0.01). The DOR antagonist, naltrindole, inhibited this, whereas CTAP, a selective mu OR antagonist, was ineffective. In addition, N-Ac-β-EP and the μ OR agonist DAMGO, failed to mimic the effects of β-EP. Although it was less potent than β-EP, DADLE, a DOR agonist, also enhanced Con-A-induced calcium mobilization (p < 0.01). A DORtransfected human T-cell line (DOR-Jul.l) was developed to study signal transduction. Both DADLE and the selective DOR agonist, deltorphin, rapidly increased intracellular free calcium concentrations; ED50s were 10-9 M. Pertussis toxin prevented the response, and EGTA significantly reduced it. In addition, DADLE inhibited forskolin-stimulated cAMP production (ED50: 10-11 M). These findings with normal splenic T cells and DOR-transfected T-cell line indicate that β-EP and DOR agonists affect calcium mobilization. This is likely to modulate downstream pathways that regulate T-cell activation and function.

AB - β-Endorphin (β-EP) and delta opoid receptor (DOR) agonists affect immune functions such as lymphocyte chemotaxis, proliferation, and cytokine production. Recent studies indicate that both neuronal DOR and novel G-protein-coupled receptors with high affinity for β-EP and DOR agonists are expressed by mononuclear cells. In addition, proenkephalin A mRNA and enkephalin-related peptides are expressed by lymphocytes. These investigations were conducted to identify signal transduction pathways that mediate the effects of β-EP and DOR agonists on T cells. Calcium mobilization was studied because it is central to T-cell activation initiated by antigen presentation to the T-cell receptor (TCR). Using the calcium-sensitive dye Fluo-3 and flow cytofluorometry to determine the concentration of free intracellular calcium, physiological concentrations of β-EP were shown to enhance concanvalin. A (con A)-stimulated calcium mobilization by murine splenic T cells (p < 0.01). The DOR antagonist, naltrindole, inhibited this, whereas CTAP, a selective mu OR antagonist, was ineffective. In addition, N-Ac-β-EP and the μ OR agonist DAMGO, failed to mimic the effects of β-EP. Although it was less potent than β-EP, DADLE, a DOR agonist, also enhanced Con-A-induced calcium mobilization (p < 0.01). A DORtransfected human T-cell line (DOR-Jul.l) was developed to study signal transduction. Both DADLE and the selective DOR agonist, deltorphin, rapidly increased intracellular free calcium concentrations; ED50s were 10-9 M. Pertussis toxin prevented the response, and EGTA significantly reduced it. In addition, DADLE inhibited forskolin-stimulated cAMP production (ED50: 10-11 M). These findings with normal splenic T cells and DOR-transfected T-cell line indicate that β-EP and DOR agonists affect calcium mobilization. This is likely to modulate downstream pathways that regulate T-cell activation and function.

UR - http://www.scopus.com/inward/record.url?scp=0032078291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032078291&partnerID=8YFLogxK

M3 - Article

VL - 840

SP - 420

EP - 421

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -